2018 annual financial data

Sutro Biopharma 2018 Operating cash flow

Direct answer

Operating cash flow was 12.68M USD.

Operating income was -37.22M USD and net income was -35.32M USD.
Operating cash flow was 12.68M USD.

Get free Sutro Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
38.42M USD
Operating income
-37.22M USD
Net income
-35.32M USD
Operating cash flow
12.68M USD